Amgen (AMGN) Current Assets (2009 - 2026)

Amgen (AMGN) has reported Current Assets for 18 consecutive years, with $31.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets rose 16.88% year-over-year to $31.5 billion; the TTM figure through Mar 2026 stood at $31.5 billion (up 16.88% YoY), while the FY2025 annual figure was $29.1 billion, changed 0.09% from the prior year.
• Current Assets came in at $31.5 billion for Q1 2026 at Amgen, up from $29.1 billion in the prior quarter.
• The five-year high for Current Assets was $48.5 billion in Q3 2023, with the low at $18.5 billion in Q1 2022.
• Average Current Assets over 5 years is $29.9 billion, with a median of $27.9 billion recorded in 2025.
• Across the five-year window, Current Assets surged 145.21% in 2023 and tumbled 44.79% in 2024, its largest moves.
• Year by year, Current Assets stood at $22.2 billion in 2022, then soared by 36.72% to $30.3 billion in 2023, then fell by 4.29% to $29.0 billion in 2024, then advanced by 0.09% to $29.1 billion in 2025, then increased by 8.32% to $31.5 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $31.5 billion, $29.1 billion, and $27.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.